Financial incentives to carry autoinjectors
It is unclear whether providing people at risk of anaphylaxis with
financial incentives increases how often they carry autoinjectors
because the certainty of evidence is very low (supplement S8b). One
trial in people aged 18 to 30 years found that financial incentives were
associated with a 27% mean increase in the proportion of people
carrying their autoinjector (statistically significant, CI not reported,
very low certainty).11Cannuscio CC, Dupuis R, Graves A, Seymour
JW, Kounaves S, Strupp E, Leri D, Frasso R, Grande D, Meisel ZF. A
behavioral economics intervention to encourage epinephrine-carrying
among food-allergic adults: a randomized controlled trial. Ann Allergy
Asthma Immunol 2015;115(3):234-240.e1.